Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease

Internal Medicine Journal

Volumn 42, Issue 2, 2012, Pages 146-153

  Turkmen, K ^a   Tufan, F ^b   Alpay, N ^b   Kasikcioglu, E ^b   Oflaz, H ^b   Ecder, S A ^c   Ecder, T ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Goztepe Training Hospital   (Turkey)

Author keywords

Autosomal domimant polycystic disease; Coronary flow velocity reserve; Insulin resistance

Indexed keywords

CHOLESTEROL; CREATININE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORONARY FLOW RESERVE; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HOMEOSTASIS MODEL INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; INTRAVASCULAR ULTRASOUND; KIDNEY POLYCYSTIC DISEASE; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 84857414668     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02404.x     Document Type: Article

References (41)

1. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008; 359: 1477-85.
2. Ecder T, Schrier RW. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-8.
3. Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 5: 2048-56.
4. Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol 2001; 12: 194-200.
5. Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1997; 8: 1292-7.
6. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1451-7.
7. Martinez-Vea A, Valero FA, Bardaji A, Gutierrez C, Broch M, Garcia C etal. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors. Am J Nephrol 2000; 20: 193-200.
8. Saggar-Malik AK, Missouris CG, Gill JS, Singer DR, Markandu ND, MacGregor GA. Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ 1994; 309: 1617-18.
9. Bardaji A, Vea AM, Gutierrez C, Ridao C, Richart C, Oliver JA. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 1998; 32: 970-5.
10. Oflaz H, Alisir S, Buyukaydin B, Kocaman O, Turgut F, Namli S etal. Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease. Kidney Int 2005; 68: 2244-9.
11. Wang D, Iversen J, Wilcox CS, Strandgaard S. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 2003; 64: 1381-8.
12. Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S etal. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2004; 43: 854-60.
13. Turkmen K, Oflaz H, Uslu B, Cimen AO, Elitok A, Kasikcioglu E etal. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol 2008; 3: 986-91.
14. Vareesangthip K, Tong P, Wilkinson R, Thomas TH. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997; 52: 503-8.
15. Vareesangthip K, Thomas TH, Tong P, Wilkonson R. Abnormal erythrocyte membrane fluidity in adult polycystic kidney disease: difference between intact cells and ghost membranes. Eur J Clin Invest 1996; 26: 171-3.
16. Vareesangthip K, Thomas TH, Wilkonson R. Abnormal effect of thiol groups on erythrocyte Na/Li countertransport kinetics in adult polycystic kidney disease. Nephrol Dial Transplant 1995; 10: 2219-23.
17. Lumiaho A, Pihlajamaki J, Hartikainen J, Ikaheimo R, Miettinen R, Niemitukia L etal. Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1. Am J Kidney Dis 2003; 41: 1219-24.
18. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-7.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
22. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL etal. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation 1980; 62: 212-17.
23. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-18.
24. Hozumi T, Yoshida K, Ogata Y, Akasaka T, Asami Y, Takagi T etal. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998; 97: 1557-62.
25. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-54.
26. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
27. Tee JB, Acott PD, McLellan DH, Crocker JF. Phenotypic heterogeneity in pediatric autosomal dominant polycystic kidney disease at first presentation: a single-center, 20-year review. Am J Kidney Dis 2004; 43: 296-303.
28. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT etal. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-19.
29. Bardaji A, Martinez-Vea A, Valero A, Gutierrez C, Garcia C, Ridao C etal. Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease. Clin Nephrol 2001; 56: 211-20.
30. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L etal. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002; 105: 186-93.
31. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003; 349: 1027-35.
32. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y etal. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997; 30: 1472-7.
33. Galiuto L, Sestito A, Barchetta S, Sgueglia GA, Infusino F, La Rosa C etal. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol 2007; 99: 1378-83.
34. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323: 1091-6.
35. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990; 15: 861-6.
36. Vensel LA, Devereux RB, Pickering TG, Herrold EM, Borer JS, Laragh JH. Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol 1986; 58: 575-82.
37. Bornfeldt KE, Skottner A, Arnqvist HJ. In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle. J Endocrinol 1992; 135: 203-11.
38. Rostrup M, Smith G, Bjornstad H, Westheim A, Stokland O, Eide I. Left ventricular mass and cardiovascular reactivity in young men. Hypertension 1994; 23: I168-71.
39. McNulty PH, Louard RJ, Deckelbaum LI, Zaret BL, Young LH. Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance. Circulation 1995; 92: 2151-6.
40. Alisir S, Turkmen K, Alpay N, Elitok A, Oflaz H, Uslu B etal. Improvement of coronary flow velocity reserve with telmisartan in patients with autosomal-dominant polycystic kidney disease. South Med J 2010; 103: 409-13.
41. Defronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-68.